News

Featured News

  • 2020 |
  • 2019 |
  • 2018 |
  • 2017 |
  • View All
  • News | July 29, 2020

    Women in Bio: Geeta Vemuri Blazes a Trail in Venture Capital

    Read More

    Press Release | July 27, 2020

    CARISMA Therapeutics Announces FDA Clearance of IND Application for First-Ever Engineered Macrophage Immunotherapy

    Read More

    News | July 23, 2020

    Clearing the Hurdles to a Career in Venture Capital; An Interview with Geeta Vemuri

    Read More

    Press Release | July 16, 2020

    Agent Capital Expands Management Team; Appoints Jacopo Leonardi as Partner

    Read More

    Press Release | July 15, 2020

    Orchard Therapeutics Announces Global License Agreements for Stable Cell Line Technology from GSK

    Read More

    Press Release | July 9, 2020

    ImCheck Therapeutics Appoints Claude Knopf as Chief Business Officer

    Read More

    Press Release | July 9, 2020

    Orchard Therapeutics and MolMed Announce Extension of Gene Therapy Manufacturing Collaboration

    Read More

    Press Release | July 8, 2020

    Precision BioSciences Announces Dosing of First Patient in Phase 1/2a Clinical Trial of PBCAR269A for Multiple Myeloma

    Read More

    News | July 6, 2020

    Bristol Myers Pays Dragonfly $55M to Bring NK Cells to Neuro Diseases

    Read More

    Press Release | July 6, 2020

    Precision BioSciences Regains Rights to In Vivo Hepatitis B Virus Program

    Read More

    Press Release | June 26, 2020

    Aptinyx to be Added to Russell 2000® Index

    Read More

    Press Release | June 18, 2020

    Aptinyx Completes Enrollment in Phase 2 Exploratory Study of NYX-783 in Post-Traumatic Stress Disorder

    Read More

    News | June 3, 2020

    Biotech Pliant Therapeutics pulls off $144M IPO to advance fibrosis pipeline

    Read More

    Press Release | May 28, 2020

    Palvella Therapeutics Completes $45 Million Series C Financing

    Read More

    Press Release | May 26, 2020

    Freenome Announces Initiation of the PREEMPT CRC Clinical Trial for the Early Detection and Prevention of Colorectal Cancer Using a Multiomics Blood Test

    Read More

    Press Release | May 19, 2020

    HalioDx to Characterize the Immune Contexture of Patients Enrolled in ImCheck’s EVICTION Phase 1/2 Clinical Trial

    Read More

    Press Release | May 15, 2020

    New Data from Carisma Therapeutics Uncover Potential of Expedited Pathway for Immunotherapy Development Through CAR Monocytes

    Read More

    Press Release | May 15, 2020

    Orchard Therapeutics Presents New Interim Data from OTL-203 Proof-of-concept Study for MPS-I

    Read More

    News | May 12, 2020

    Merck doubles down on Skyhawk’s tech to drug RNA, promising $600M per autoimmune, metabolic target

    Read More

    News | March 31, 2020

    Latest Penn biotech spinout taking on cancer raises $1.6M from investors

    Read More

    Press Release | March 26, 2020

    First Patient Dosed in EVICTION Trial Evaluating ImCheck’s Lead Anti-Cancer Drug, ICT01: A Novel Gamma Delta T Cell-Activating Immunotherapy

    Read More

    News | March 23, 2020

    First-of-its-kind Engineered Macrophage Cell Therapy Platform Shows Ability to Reduce Tumor Burden and Activate Anti-Tumor Immunity, Improving Overall Survival in Pre-Clinical Cancer Models

    Read More

    Press Release | March 23, 2020

    Pliant Therapeutics Initiates First-in-Human Clinical Trial of PLN-1474 for the Potential Treatment of Liver Fibrosis

    Read More

    Press Release | March 17, 2020

    ImCheck Therapeutics Expands Leadership Team with Appointment of Hans Henrik Chrois Christensen as Chief Financial Officer and Chief Operating Officer

    Read More

    Press Release | March 3, 2020

    Pliant Therapeutics Raises $100 Million in Series C Financing to Advance Therapies for Fibrotic Diseases

    Read More

    News | January 23, 2020

    Business Wire Freenome Announces Encouraging Performance Data for Its Multiomics Blood Test to Detect Early-Stage Colorectal Cancer in a Prospective, Multi-Center Clinical Study

    Read More

    Press Release | January 8, 2020

    Entrada Therapeutics Announces ENTR-501 for the Treatment of Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE)

    Read More

    Press Release | January 6, 2020

    Carisma Therapeutics Expands Leadership Team

    Read More

    Press Release | December 4, 2019

    ImCheck Raises $53 Million Series B to Advance Clinical Pipeline of Novel Gamma Delta T-Cell-Focused Antibodies for Cancer and Autoimmune Diseases

    Read More

    Press Release | November 8, 2019

    Precision BioSciences Announces the Presentation of Initial Clinical Data Supporting the Safety and Clinical Activity of PBCAR0191, a Novel CD19 Targeted Allogeneic CAR T Therapy Candidate, at the American Society of Hematology Annual Meeting

    Read More

    Press Release | November 6, 2019

    Orchard Therapeutics to Present New Registrational Data of Investigational Gene Therapies at the 61st American Society of Hematology Annual Meeting

    Read More

    Press Release | October 28, 2019

    Aptinyx Announces Results of Phase 2 Fibromyalgia Study of NYX-2925 Have Been Selected for Late-Breaking Presentation at the American College of Rheumatology Annual Meeting

    Read More

    News | October 23, 2019

    Novartis bets $80M on Pliant’s preclinical NASH prospect

    Read More

    News | July 19, 2019

    Pyxis Oncology Raises $22 Million Series A

    Read More

    News | July 16, 2019

    Genentech inks its latest discovery deal — this time turning to RNA upstart Skyhawk

    Read More

    News | July 8, 2019

    Fattening the bankroll, Bill Haney adds cancer R&D powerhouse Merck to Skyhawk’s roster of partners out to drug RNA

    Read More

    News | June 10, 2019

    Aptinyx Reports Top-line Data from Phase 2 in Patients with Fibromyalgia

    Read More

    News | June 3, 2019

    Carisma Therapeutics Names Dr. Robert Petit As Chief Scientific Officer

    Read More

    News | May 27, 2019

    Carisma Therapeutics Featured in Nature Biotechnology’s Top Academic Spin-outs 2018

    Read More

    Press Release | May 14, 2019

    Precision BioSciences Appoints Christopher R. Heery, M.D., as Chief Medical Officer

    Read More

    Press Release | May 6, 2019

    Skyhawk Therapeutics Announces Agreement with Takeda for Neurodegenerative Diseases

    Read More

    News | April 9, 2019

    Pliant Therapeutics Reports Positive Results Of Phase 1 Clinical Study

    Read More

    News | March 1, 2019

    Genome editing company Precision proposes $100M IPO

    Read More

    News | January 16, 2019

    Aptinyx Reports Top-line Results from Phase 2 Clinical Study of NYX-2925 in Painful Diabetic Peripheral Neuropathy

    Read More

    Press Release | January 4, 2019

    Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers for Neurological Disease Targets

    Read More

    News | January 3, 2019

    Pliant Therapeutics Initiates Phase 1 Clinical Study of PLN-74809

    Read More

    News | December 18, 2018

    Palvella Therapeutics Announces $10 Million in Funding from Ligand Pharmaceuticals to Accelerate PTX-022 through Phase 2/3 Clinical Study in Pachyonychia Congenita

    Read More

    Press Release | December 18, 2018

    Entrada Therapeutics Raises $59 Million Series A to Advance Intracellular Biologics Platform

    Read More

    Press Release | December 13, 2018

    Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California

    Read More

    Press Release | December 6, 2018

    Precision BioSciences and Durham STEM Students Lead Launch of First Genome Editing Experiment Into Space

    Read More

    News | November 27, 2018

    Precision BioSciences Receives FDA Authorization to Initiate Clinical Study of Gene Edited Cancer Immunotherapy

    Read More

    News | November 20, 2018

    Pliant Therapeutics Receives FDA Orphan Drug Designation for Lead Program PLN-74809 in Primary Sclerosing Cholangitis

    Read More

    News | November 5, 2018

    Orchard Therapeutics Announces Closing of $225 Million Initial Public Offering

    Read More

    Press Release | July 16, 2018

    Pliant Therapeutics Raises $62 Million in Series B Financing

    Read More

    Press Release | July 16, 2018

    Verge Genomics Announces $32 Million Series A

    Read More

    News | June 27, 2018

    Carisma Nabs $53 Million Series A for Cellular Cancer Therapy

    Read More

    Press Release | June 26, 2018

    Skyhawk Therapeutics Announces $40 Million Equity Investment Round

    Read More

    News | June 26, 2018

    Kauffman Fellows Celebrates Its Most Diverse Group of Talented Leaders With Class 23

    Read More

    News | June 26, 2018

    Genome Editing Startup Precision BioSciences Scores $110 Million Series B

    Read More

    Press Release | June 26, 2018

    Precision BioSciences Raises $110M

    Read More

    News | June 26, 2018

    Skyhawk Therapeutics Gains $100 Million Through Venture Round, Collaboration

    Read More

    News | June 26, 2018

    CAR Macrophage Tumor Tech Created by UPenn Star Scientists Gets $53M

    Read More

    Press Release | June 20, 2018

    Aptinyx Announces Pricing of Initial Public Offering

    Read More

    News | April 12, 2018

    UK Gene Therapy Firm Orchard Plans Stock Offer After GSK Deal

    Read More

    Press Release | December 20, 2017

    Orchard Therapeutics Announces $110M Series B Financing

    Read More

    Press Release | December 18, 2017

    Aptinyx Raises $70 Million in Series B Financing

    Read More